Senior insider sale
Chief Scientific Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$2.45M
92.78K shares
LILLIE JAMES WOODRUFF plans to sell 92.78K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $2.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Vested RSU
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/18/2025 | Vested RSU N/A | 22.08K | — |
| Total | 22.08K | ||
Completed
Units to sell
2.08K
Market value
$78.7K
Units to sell
8.55K
Market value
$314.4K
Units to sell
7.64K
Market value
$280.4K
Units to sell
721.00
Market value
$20.4K
Units to sell
24.81K
Market value
$713.7K
Units to sell
11.10K
Market value
$312.8K
Units to sell
15.80K
Market value
$441.8K
Planned — Approximate Date
Units to sell
22.08K
Market value
$287.5K
Units
92.78K
Value
$2.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/17/2026 | 2.08K | $78.7K | — | Completed |
7/16/2026 | 8.55K | $314.4K | — | Completed |
7/15/2026 | 7.64K | $280.4K | — | Completed |
5/7/2026 | 721.00 | $20.4K | — | Completed |
5/6/2026 | 24.81K | $713.7K | — | Completed |
5/5/2026 | 11.10K | $312.8K | — | Completed |
5/4/2026 | 15.80K | $441.8K | — | Completed |
| Planned — Approximate Date | ||||
8/3/2026 | 22.08K | $287.5K | NASDAQ | Planned |
| Total | 92.78K | $2.45M | ||